HCSA Community Services and Tan Tock Seng Hospital (TTSH) have signed a Memorandum of Understanding (MoU) to bolster efforts in eliminating Hepatitis C (HCV) among former drug offenders in Singapore. This collaboration, announced on World Hepatitis Day, is part of the Educate, Test, Treat! (ETT) initiative, which began in 2022 with support from Gilead Sciences.
The MoU, witnessed by Mdm Rahayu Mahzam, Minister of State, Ministry of Health and Ministry of Digital Development and Information, aims to enhance HCV screening and treatment accessibility. The initiative will employ saliva-based testing, eliminating the need for blood draws, and provide specialist medical support. From August 2025 to the end of 2026, the programme targets screening up to 600 individuals.
TTSH will offer a comprehensive range of services, including educational outreach, HCV screenings, and antiviral therapy. The hospital will also connect patients with HCSA for financial guidance. The first phase of the ETT initiative in 2023 successfully recruited 210 participants, whilst Phase 2, launched in 2024, has reached 85% of its 400-participant target.
Kim Lang Khalil, CEO of HCSA Community Services, emphasised the partnership’s role in restoring hope and health to former drug offenders. Dr Yew Kuo Chao of TTSH highlighted the hospital’s commitment to community care. Cathy Su of Gilead Sciences noted the growing strength of partnerships in achieving the World Health Organisation’s hepatitis elimination goals.
This initiative represents a significant step in addressing health disparities and ensuring vulnerable populations receive necessary care.
“`